Join Ascendia at the Controlled Release Society Annual Meeting in Las Vegas

Jul 12, 2023 12:00:00 AM

Ascendia Pharmaceutical Solutions Develops Novel Nanoemulsion IV Formulation for Clopidogrel that Received IND Approval

Jul 10, 2023 12:00:00 AM

Ascendia Pharmaceutical Solutions is Hiring!

Jun 22, 2023 12:00:00 AM

KCAS and Ascendia Pharmaceutical Solutions: A Perfect Union Of Services

Jun 19, 2023 12:00:00 AM

Ascendia “All-In” on Lipid Nanoparticle Formulations for Your Project Needs

May 24, 2023 12:00:00 AM

Ascendia to Highlight Expanded Manufacturing, New Technologies at BIO 2023

May 15, 2023 12:00:00 AM

Ascendia Pharmaceutical Solutions will be at CPHI North America in Philadelphia – and We Have More Good News to Share with You

Apr 18, 2023 12:00:00 AM

Ascendia Pharmaceutical Solutions to Commence Phase III and Commercial Product Manufacturing

Apr 6, 2023 12:00:00 AM

Solubility Screening and Process Scale-up Services from Ascendia

Mar 16, 2023 12:00:00 AM

Ascendia Expands Sterile/Non-Sterile HQ to Nearly 60,000 Square Feet at NJ Bioscience Center in North Brunswick

Mar 13, 2023 12:00:00 AM

Ascendia Pharmaceuticals to Attend Annual DCAT Week and Will Unveil New Services!

Mar 9, 2023 12:00:00 AM

Ascendia’s Reactions to the Themes We Came Away with from this Year’s JP Morgan Healthcare Conference

Feb 15, 2023 12:00:00 AM